植物家族Amaryllidaceae的抗炎作用
Jerald J Nair1, Johannes van Staden1
1Research Centre for Plant Growth and Development, School of Life Sciences, University of KwaZulu-Natal Pietermaritzburg, Private Bag X01, Scottsville, 3209, South Africa.
亚马里里叶科植物家族显示出显著的抗炎潜力,传统用途和科学研究强调其在伤口愈合和疼痛管理方面的有效性. 进一步的研究可能会从这个家族中获得新的抗炎药物.
科学领域:
- 民族植物学和药理学
- 药用植物研究 药用植物研究
背景情况:
- 在传统医学中,Amaryllidaceae植物得到了认可,特别是用于治疗炎症疾病.
- 支持其抗炎用途的证据来自全球各个地区.
研究的目的:
- 识别用于炎症的阿马里里氏种类,它们的起源和应用.
- 为了评估Amaryllidaceae提取物的体外和体内抗炎活性.
- 阐明这些抗炎作用背后的分子机制.
主要方法:
- 在主要的科学数据库 (SciFinder,Scopus,PubMed,Google Scholar) 进行了全面的文献搜索.
- 关键词包括"Amaryllidaceae"",炎症"和"抗炎",以及属性特定的术语.
- 从600多个初步结果中,大约有170篇文章被选中进行审查.
主要成果:
- 来自35个国家的51种Amaryllidaceae物种用于治疗24种炎症状况,特别是用于伤口愈合和疼痛管理.
- 73种物种的提取物在体外和体内表现出显著的抗炎活性,细胞毒性最小.
- 观察到的机制包括调节促炎因素 (例如NF-κB,TNF-α,IL-6) 和抗炎因素 (例如IL-10).
结论:
- 亚玛利利叶科植物是抗炎研究的有希望的来源.
- 来自传统医学和科学研究的强有力的证据支持它们的治疗潜力.
- 这一家族中的类化合物可能会导致新型抗炎化疗药物的开发.
更多相关视频
09:21Inhibition of Aspergillus flavus Growth and Aflatoxin Production in Transgenic Maize Expressing the α-amylase Inhibitor from Lablab purpureus L.
Published on: February 15, 2019
07:50Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
Published on: July 16, 2012
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
